-
1
-
-
69949090646
-
BD Phoenix and Vitek 2 detection of mecA-mediated resistance in Staphylococcus aureus with cefoxitin
-
Junkins AD, Lockhart SR, Heilmann KP, Dohrn CL, Von Stein DL, Winokur PL, Doern GV, Richter SS. 2009. BD Phoenix and Vitek 2 detection of mecA-mediated resistance in Staphylococcus aureus with cefoxitin. J. Clin. Microbiol. 47:2879-2882. http://dx.doi.org/10.1128/JCM.01109-09.
-
(2009)
J. Clin. Microbiol.
, vol.47
, pp. 2879-2882
-
-
Junkins, A.D.1
Lockhart, S.R.2
Heilmann, K.P.3
Dohrn, C.L.4
Von Stein, D.L.5
Winokur, P.L.6
Doern, G.V.7
Richter, S.S.8
-
2
-
-
77950509581
-
Performance of an agar dilution method and a Vitek 2 card for detection of inducible clindamycin resistance in Staphylococcus spp
-
Lavallée C, Rouleau D, Gaudreau C, Roger M, Tsimiklis C, Locas MC, Gagnon S, Delorme J, Labbé A. 2010. Performance of an agar dilution method and a Vitek 2 card for detection of inducible clindamycin resistance in Staphylococcus spp. J. Clin. Microbiol. 48:1354-1357. http://dx.doi.org/10.1128/ JCM.01751-09.
-
(2010)
J. Clin. Microbiol.
, vol.48
, pp. 1354-1357
-
-
Lavallée, C.1
Rouleau, D.2
Gaudreau, C.3
Roger, M.4
Tsimiklis, C.5
Locas, M.C.6
Gagnon, S.7
Delorme, J.8
Labbé, A.9
-
3
-
-
84856612590
-
Comparison of BD Phoenix and bioMérieux Vitek 2 automated systems for the detection of macrolide-lincosamide-streptogramin B resistance among clinical isolates of Staphylococcus
-
Buchan BW, Anderson NW, Ledeboer NA. 2012. Comparison of BD Phoenix and bioMérieux Vitek 2 automated systems for the detection of macrolide-lincosamide-streptogramin B resistance among clinical isolates of Staphylococcus. Diagn. Microbiol. Infect. Dis. 72:291-294. http://dx.doi.org/10. 1016/j.diagmicrobio.2011.12.003.
-
(2012)
Diagn. Microbiol. Infect. Dis.
, vol.72
, pp. 291-294
-
-
Buchan, B.W.1
Anderson, N.W.2
Ledeboer, N.A.3
-
4
-
-
77952983015
-
Analysis of methods commonly used for glycopeptide and oxazolidinone susceptibility testing in Enterococcus faecium isolates
-
Raponi G, Ghezzi MC, Gherardi G, Lorino G, Dicuonzo G. 2010. Analysis of methods commonly used for glycopeptide and oxazolidinone susceptibility testing in Enterococcus faecium isolates. J. Med. Microbiol. 59:672-678. http://dx.doi.org/10.1099/jmm.0.016444-0.
-
(2010)
J. Med. Microbiol.
, vol.59
, pp. 672-678
-
-
Raponi, G.1
Ghezzi, M.C.2
Gherardi, G.3
Lorino, G.4
Dicuonzo, G.5
-
5
-
-
34548684315
-
Accuracy of six antimicrobial susceptibility methods for testing linezolid against staphylococci and enterococci
-
Tenover FC, Williams PP, Stocker S, Thompson A, Clark LA, Limbago B, Carey RB, Poppe SM, Shinabarger D, McGowan JE. 2007. Accuracy of six antimicrobial susceptibility methods for testing linezolid against staphylococci and enterococci. J. Clin. Microbiol. 45:2917-2922. http://dx.doi.org/10.1128/ JCM.00913-07.
-
(2007)
J. Clin. Microbiol.
, vol.45
, pp. 2917-2922
-
-
Tenover, F.C.1
Williams, P.P.2
Stocker, S.3
Thompson, A.4
Clark, L.A.5
Limbago, B.6
Carey, R.B.7
Poppe, S.M.8
Shinabarger, D.9
McGowan, J.E.10
-
6
-
-
12144260815
-
Detection of inducible clindamycin resistance of staphylococci in conjunction with performance of automated broth susceptibility testing
-
Jorgensen JH, Crawford SA, McElmeel ML, Fiebelkorn KR. 2004. Detection of inducible clindamycin resistance of staphylococci in conjunction with performance of automated broth susceptibility testing. J. Clin. Microbiol. 42: 1800-1802. http://dx.doi.org/10.1128/JCM.42.4.1800-1802.2004.
-
(2004)
J. Clin. Microbiol.
, vol.42
, pp. 1800-1802
-
-
Jorgensen, J.H.1
Crawford, S.A.2
McElmeel, M.L.3
Fiebelkorn, K.R.4
-
7
-
-
67650090507
-
Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus
-
Swenson JM, Anderson KF, Lonsway DR, Thompson A, McAllister SK, Limbago BM, Carey RB, Tenover FC, Patel JB. 2009. Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus. J. Clin. Microbiol. 47: 2013-2017. http://dx.doi.org/10. 1128/JCM.00221-09.
-
(2009)
J. Clin. Microbiol.
, vol.47
, pp. 2013-2017
-
-
Swenson, J.M.1
Anderson, K.F.2
Lonsway, D.R.3
Thompson, A.4
McAllister, S.K.5
Limbago, B.M.6
Carey, R.B.7
Tenover, F.C.8
Patel, J.B.9
-
8
-
-
84873859337
-
Inducible resistance to clindamycin in Staphylococcus aureus: Validation of Vitek-2 against CLSI D-test
-
Gardiner BJ, Grayson ML, Wood GM. 2013. Inducible resistance to clindamycin in Staphylococcus aureus: validation of Vitek-2 against CLSI D-test. Pathology 45:181184. http://dx.doi.org/10.1097/PAT.0b013e32835cccda.
-
(2013)
Pathology
, vol.45
, pp. 181184
-
-
Gardiner, B.J.1
Grayson, M.L.2
Wood, G.M.3
-
9
-
-
84893117416
-
-
bioMérieux. 2013. VITEK 2 AST-GP71 product information. bioMérieux, Inc., Durham, NC.
-
bioMérieux. 2013. VITEK 2 AST-GP71 product information. bioMérieux, Inc., Durham, NC.
-
-
-
-
10
-
-
84893066557
-
-
bioMérieux. 2013. VITEK 2 AST-GP72 product information. bioMérieux, Inc., Durham, NC.
-
bioMérieux. 2013. VITEK 2 AST-GP72 product information. bioMérieux, Inc., Durham, NC.
-
-
-
-
12
-
-
79951485149
-
-
Coordinating ed, Sharp SE. ASM Press, Washington, DC
-
Clark RB, Lewinski MA, Loeffelholz MJ, Thibbetts RJ. 2009. Cumitech 31A, Verification and validation of procedures in the clinical microbiology laboratory. Coordinating ed, Sharp SE. ASM Press, Washington, DC.
-
(2009)
Cumitech 31A, Verification and Validation of Procedures in the Clinical Microbiology Laboratory
-
-
Clark, R.B.1
Lewinski, M.A.2
Loeffelholz, M.J.3
Thibbetts, R.J.4
-
13
-
-
23744453764
-
Analysis of the comparative workflow and performance characteristics of the VITEK 2 and Phoenix systems
-
Eigner U, Schmid A, Wild U, Bertsch D, Fahr AM. 2005. Analysis of the comparative workflow and performance characteristics of the VITEK 2 and Phoenix systems. J. Clin. Microbiol. 43:3829-3834. http://dx.doi.org/10.1128/JCM.43.8. 3829-3834.2005.
-
(2005)
J. Clin. Microbiol.
, vol.43
, pp. 3829-3834
-
-
Eigner, U.1
Schmid, A.2
Wild, U.3
Bertsch, D.4
Fahr, A.M.5
-
14
-
-
0034884831
-
Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance
-
Drinkovic D, Fuller ER, Shore KP, Holland DJ, Ellis-Pegler R. 2001. Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J. Antimicrob. Chemother. 48:315-316. http://dx.doi.org/10.1093/jac/ 48.2.315.
-
(2001)
J. Antimicrob. Chemother.
, vol.48
, pp. 315-316
-
-
Drinkovic, D.1
Fuller, E.R.2
Shore, K.P.3
Holland, D.J.4
Ellis-Pegler, R.5
-
15
-
-
0242574929
-
Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro
-
Siberry GK, Tekle T, Carroll K, Dick J. 2003. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin. Infect. Dis. 37:1257-1260. http://dx.doi.org/10.1086/377501.
-
(2003)
Clin. Infect. Dis.
, vol.37
, pp. 1257-1260
-
-
Siberry, G.K.1
Tekle, T.2
Carroll, K.3
Dick, J.4
-
16
-
-
0035990367
-
Clindamycin treatment of methicillinresistant Staphylococcus aureus infections in children
-
Frank AL, Marcinak JF, Mangat PD, Tjhio JT, Kelkar S, Schreckenberger PC, Quinn P. 2002. Clindamycin treatment of methicillinresistant Staphylococcus aureus infections in children. Pediatr. Infect. Dis. J. 21:530-534. http://dx.doi.org/10.1097/00006454-200206000-00010.
-
(2002)
Pediatr. Infect. Dis. J.
, vol.21
, pp. 530-534
-
-
Frank, A.L.1
Marcinak, J.F.2
Mangat, P.D.3
Tjhio, J.T.4
Kelkar, S.5
Schreckenberger, P.C.6
Quinn, P.7
-
17
-
-
79960950114
-
Adherence to CLSI recommendations for testing of Staphylococcus aureus isolates in Louisiana hospitals: Report of a clinical failure and results of a questionnaire study
-
Patra KP, Vanchiere JA, Bocchini JA. 2011. Adherence to CLSI recommendations for testing of Staphylococcus aureus isolates in Louisiana hospitals: report of a clinical failure and results of a questionnaire study. J. Clin. Microbiol. 49:3019-3020. http://dx.doi.org/10.1128/JCM.00944-11.
-
(2011)
J. Clin. Microbiol.
, vol.49
, pp. 3019-3020
-
-
Patra, K.P.1
Vanchiere, J.A.2
Bocchini, J.A.3
-
18
-
-
15944426803
-
Prevalence of inducible clindamycin resistance in macrolide-resistant Staphylococcus spp
-
Fokas S, Tsironi M, Kalkani M, Dionysopouloy M. 2005. Prevalence of inducible clindamycin resistance in macrolide-resistant Staphylococcus spp. Clin. Microbiol. Infect. 11:337-340. http://dx.doi.org/10.1111/j.1469-0691.2005. 01101.x.
-
(2005)
Clin. Microbiol. Infect.
, vol.11
, pp. 337-340
-
-
Fokas, S.1
Tsironi, M.2
Kalkani, M.3
Dionysopouloy, M.4
-
19
-
-
33746211170
-
Prevalence of inducible clindamycin resistance among community-and hospitalassociated Staphylococcus aureus isolates
-
Patel M, Waites KB, Moser SA, Cloud GA, Hoesley CJ. 2006. Prevalence of inducible clindamycin resistance among community-and hospitalassociated Staphylococcus aureus isolates. J. Clin. Microbiol. 44:2481-2484. http://dx.doi.org/10.1128/JCM.02582-05.
-
(2006)
J. Clin. Microbiol.
, vol.44
, pp. 2481-2484
-
-
Patel, M.1
Waites, K.B.2
Moser, S.A.3
Cloud, G.A.4
Hoesley, C.J.5
-
20
-
-
2942564178
-
Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital
-
Schreckenberger PC, Ilendo E, Ristow KL. 2004. Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital. J. Clin. Microbiol. 42:2777-2779. http://dx.doi.org/10.1128/JCM.42.6.2777-2779. 2004.
-
(2004)
J. Clin. Microbiol.
, vol.42
, pp. 2777-2779
-
-
Schreckenberger, P.C.1
Ilendo, E.2
Ristow, K.L.3
-
21
-
-
33847670929
-
Detection and prevalence of inducible clindamycin resistance in staphylococci
-
Yilmaz G, Aydin K, Iskender S, Caylan R, Koksal I. 2007. Detection and prevalence of inducible clindamycin resistance in staphylococci. J. Med. Microbiol. 56:342-345. http://dx.doi.org/10.1099/jmm.0.46761-0.
-
(2007)
J. Med. Microbiol.
, vol.56
, pp. 342-345
-
-
Yilmaz, G.1
Aydin, K.2
Iskender, S.3
Caylan, R.4
Koksal, I.5
-
22
-
-
84864439400
-
Should laboratories test methicillinresistant Staphylococcus aureus for elevated vancomycin minimum inhibitory concentrations by Etest as a driver of treatment changes?
-
Humphries RM, Hindler JA. 2012. Should laboratories test methicillinresistant Staphylococcus aureus for elevated vancomycin minimum inhibitory concentrations by Etest as a driver of treatment changes? Clin. Infect. Dis. 55:612-613. http://dx.doi.org/10.1093/cid/cis469.
-
(2012)
Clin. Infect. Dis.
, vol.55
, pp. 612-613
-
-
Humphries, R.M.1
Hindler, J.A.2
-
23
-
-
84455170136
-
VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivoselected clinical strains of methicillin-resistant Staphylococcus aureus
-
Mehta S, Cuirolo AX, Plata KB, Riosa S, Silverman JA, Rubio A, Rosato RR, Rosato AE. 2012. VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivoselected clinical strains of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 56:92-102. http://dx.doi.org/10.1128/AAC.00432-10.
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, pp. 92-102
-
-
Mehta, S.1
Cuirolo, A.X.2
Plata, K.B.3
Riosa, S.4
Silverman, J.A.5
Rubio, A.6
Rosato, R.R.7
Rosato, A.E.8
-
24
-
-
79951833552
-
Daptomycin nonsusceptible enterococci: An emerging challenge for clinicians
-
Kelesidis T, Humphries R, Uslan DZ, Pegues DA. 2011. Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin. Infect. Dis. 52:228-234. http://dx.doi.org/10.1093/cid/ciq113.
-
(2011)
Clin. Infect. Dis.
, vol.52
, pp. 228-234
-
-
Kelesidis, T.1
Humphries, R.2
Uslan, D.Z.3
Pegues, D.A.4
-
25
-
-
84868018494
-
Genotypic and phenotypic evaluation of the evolution of high-level daptomycin nonsusceptibility in vancomycin-resistant Enterococcus faecium
-
Humphries RM, Kelesidis T, Tewhey R, Rose WE, Schork N, Nizet V, Sakoulas G. 2012. Genotypic and phenotypic evaluation of the evolution of high-level daptomycin nonsusceptibility in vancomycin-resistant Enterococcus faecium. Antimicrob. Agents Chemother. 56:6051-6053. http://dx.doi.org/10.1128/AAC.01318- 12.
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, pp. 6051-6053
-
-
Humphries, R.M.1
Kelesidis, T.2
Tewhey, R.3
Rose, W.E.4
Schork, N.5
Nizet, V.6
Sakoulas, G.7
-
26
-
-
84880763052
-
Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome
-
Kelesidis T, Tewhey R, Humphries RM. 2013. Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome. J. Antimicrob. Chemother. 68:1926-1928. http://dx.doi.org/10.1093/jac/dkt117.
-
(2013)
J. Antimicrob. Chemother.
, vol.68
, pp. 1926-1928
-
-
Kelesidis, T.1
Tewhey, R.2
Humphries, R.M.3
-
27
-
-
84880740988
-
Susceptibility of enterococci to daptomycin is dependent upon testing methodology
-
Bryant KA, Roberts AL, Rupp ME, Anderson JR, Lyden ER, Fey PD, Van Schooneveld TC. 2013. Susceptibility of enterococci to daptomycin is dependent upon testing methodology. Diagn. Microbiol. Infect. Dis. 76:497-501. http://dx.doi.org/10.1016/j.diagmicrobio.2013.04.019.
-
(2013)
Diagn. Microbiol. Infect. Dis.
, vol.76
, pp. 497-501
-
-
Bryant, K.A.1
Roberts, A.L.2
Rupp, M.E.3
Anderson, J.R.4
Lyden, E.R.5
Fey, P.D.6
Van Schooneveld, T.C.7
|